IRODALOMJEGYZÉK
1. Communication from the ASGE Standard of Practice Committee. Ethnic issues in
endoscopy. Gastrintest Endosc 2010;71(7): 1108-12.
2. Sonnenberg A, Lash RH, Genta RM.: A National Study of Helicobactor pylori
Infection in Gastric Biopsy Specimens. Gastroenterology 2010;139:1894-901.
3. Enders K. Ng, Wu DC, Uedo N, Gotoda T, Goh KL, Kachintorn U et al.: Risk Factors
Predicting Presence of Intestinal Metaplasia and Dysplasia in Stomach: Findings of a
Multicenter Gastroscopy Screening Study in the Asia Pacific Region.
Gastroenterology 2010;138 (S1): 292-93.
4. Kochhar R, Poornachandra KS, Dutta U, Agrawal A, Singh K.: Early endoscopic
balloon dilation in caustic-induced gastric injury. Gastrointest Endosc 2010;71(4):737-
44.
5. Kawamura M, Abe S, Oikawa K, Terai S, Saito M, Shibuya D et al. Topographic
differences in gastric micromucosal patterns observed by magnifying endoscopy with
narrow band imaging. J Gastroenterol Hepatol 2010 Oct 18.[Epub ahead of print]
6. Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD et al.: Distinguishing
Ménétrier’s disease from its mimics. Gut 2010;59(12):1617-24.
7. Kuo P, Pieterse S, Harley HA.: The Stomach That “Cracked” Under Pressure.
Gastroenterology 2010;138:44-45.
8. Hokama A, Taira K, Yamamoto Y, Kinjo N, Kinjo F, Takahashi H et al.
:Cytomegalovirus gastritis. World J Gastrointest Endosc 2010;2(11):379-80.
9. Wu D-C., Hsu P-I., Wu J-Y.: Sequential and concomitant therapy with four drugs is
equally effective for eradication of H. pylori infection Clin Gastroenterol Hepatol
2010;8:36:41
10. Zullo A., Hassan C., Cristofari F. et al..: Effects of Helicobacter pylori ereadication on
early stage gastric mucosa-associated lymphoid tissue lymphoma Clin Gastroenterol
Hepatol 2010;8:105110
11. Bao Y.,Spiegelman D., Li R.: History of peptic ulcer diesease and pancreatic cancer
risk in men Gastroenterology 2010;138:541-49
12. Sethy P. Goenka M., Majumer S.: Helicobacter negativity in NSAID negative peptic
ulcers: increasing trend form India Amer J Gastroenterol 2010;105 (Suppl 1):S31
13. Ford AC., Thabane M., Collins SM.: Prevalence of univestigated dyspepsia 8 years
after a large waterborne outbreak of bacterial dysentery: a cohort study
Gastroenterology 2010;138:1727-36
14. Zagari RM., Law GR., Fuccio L. et al..: Epidemiology of functional dyspepsia and
subgroups in the Italian general population: An endoscopic study Gastroenterology
2010;138:1302-1311
15. Communication from the ASGE Standard of Practice Committee. The role of
endoscopy in the management of patients with peptic ulcer disease. Gastrintest Endosc
2010;71(4): 663-68.
16. Yang Y-X. Metz DC.: Safety of proton pump inhibitor exposure Gastroenterology
2010;139:1115-27
17. Corley DA., Kubo A., Zhao W., Quesenberry C.: Proton pump inhibitors and
histamine-2 receptor antagonists are associated with hip fractures among at-risk
patients Gastroenterology 2010;138:93-101
18. Cardinal L., Shankar U., Sharma S. et al.: Systematic review and synthesis: a proton
pump inhibitor exposure duration and association with hip fracture Am J
Gastreoenterol 2010;105 (Suppl.1.):S29-30
19. Ditah I., Kutait A., Janarthanan S. et al.: Do proton pump inhibitors increase the risk
of bone fractures? A meta-analysis of 14 observational studies Am J Gastroenterol
2010;105(Suppl 1):S40
20. Targownik LE., Lix LM., Leslie WD.: Proton-pump inhibitor use is not associated with
osteoporosis or accelerated bone minaral density loss Gastroenterology
2010;138:896-904
21. Wu C-Y., Chan F K-L., Wu M-S. et al.: Histamine2-receptor antagonists are an
alternative to proton pump inhibitor in patients receiving clopidogrel Gastroenterology
2010;139:1156-71
22. Lombardo L., Foti M, Ruggia O., Chiecchio A.: Increased incidence of small intestine
bacterial overgrowth durong proton pump inhibitor therapy Clin Gastreonterol Hepatol
2010;8:504-8
23. Chey WD.: Proton pump inhibitors, irritable bowel syndroma, and small intestinal
bacterial overgrowth: coincidence or Newton’s third law revisted? Clin Gastroenterol
Hepatol 2010;8:480-2
24. Huang E., Strate L., Ho W. et al.: A prospective study of aspirin use and the risk of
gastrointestinal bleeding in men Am J Gastroenterol 2010;105(Suppl 1):S33
25. Vilaichone R., Janprampree K., Mahachai V. et al.: Risk of gastrointestinal bleeding
in NSAIDs users with Helicobacter pylori infection in Thailand Am J Gastroenterol
2010;105(Suppl1):S36
26. Sung JJY., Lau JYW., Ching JYL et al.: Continuation of low-dose aspirin therapy in
peptic ulcer bleeding Ann Intern Med 2010;152:1-20
27. Anjiki H, Kamisawa T, Sanaka M, Ishii T, Kuyama Y.: Endoscopic hemostasis
techniques for upper gastrointestinal hemorrhage: A review. World J Gastrintest
Endosc 2010; 16(2): 54-60.
28. Lau J, Sung JY.: From Endoscopic Hemostasis to Bleeding Peptic Ulcers: Strategies to
Prevent and Treat Recurrent Bleeding. Gastroenterology 2010;138:1252-54.
29. Wai Yan Chiu P, Yao Yiu Sung J.: High Risk Ulcer Bleeding: When Is Second-Look
Endoscopy Recommended? Clin Gastroenterol Hepatol 2010;8:651-54.
30. Maiss J, Schwab D, Ludwig A, Naegel A, Ende A, Hahn G et al.: Medical and
endoscopic treatment in peptic ulcer bleeding: a national German survey. Z
Gastroenterol 2010;48(2):246-55.
31. Nguyen GC, Dinani AM, Pivovarov K:. Endoscopic management and outcomes of
pregnant women hospitalized for nonvariceal upper GI bleeding: a nationwide
analysis. Gastrointest Endosc 2010;72(5):954-59.
32. Barkun AN, Bardou M, Martel M, Gralnek IM, Sung JJ.: Prokinetics in acute upper GI
bleeding: a meta-analysis. Gastrointest Endosc 2010;72(6):1138-45.
33. Farooq FT, Lee MH, Das A, Dixit R, Wong RC.: Clinical triage decision vs risk scores
in predicting the need for endotherapy in upper gastrointestinal bleeding. Am J Emerg
Med 2010 Dec 23. [Epub ahead of print]
34. Sung JJ, Lau, JY, Ching J, Wu JC, Lee YT, Chiu PW et al.: Continuation of low-dose
aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med
2010;152(1):1–9.
35. Egger K, Allescher HD.: Antiplatelet therapy during gastrointestinal bleeding: risk or
benefit? Gastroenterology 2010;139(2):687-89.
36. Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AET, Jin B.: Low Incidence of Complications
From Endoscopic Gastric Variceal Obturation With Butyl Cyanoacrylate. Clin
Gastroenterol Hepatol 2010;8:760–66.
37. Zhu H, Shi B, Upadhyaya M, Wu Z, Lin X, Wu Y, Chen K: Therapeutic endoscopy
of localized gastric varices: pretherapy screening and posttreatment evaluation
with MDCT portography. Abdom Imag (2010) 35:15-22
38. Kodashima S., Miki K., Fujishiro M et al.: Usefulness of a new gastric cancer
screening program using the combination assay of serum Helicobacter pylori IgG
antibody and the serum pepsinogen levels Am J Gastroenterol 2010;105(Suppl
1):S38
39. Capelle LG., Van Grieken NCT., Lingsma HF. et al.: Risk and epidemilogical time
trends of gastric cancer in Lynch syndrome carriers in the Netherlands
Gastroenterology 2010;138:487-92
40. Song HJ., Srivastava A., Lee J et al.: Host inflammatory response predicts survival
of patients with Epstein-Barr virus-associated gastric carcinoma Gastroenterology
2010;139:84-92
41. Steevens J., Van den Brandt PA., Goldbohm RA., Schouten LJ.: Selenium status
and the risk of esophageal and gastric cancer subtypes: the Netherland Cohort
Study Gastroenterology 2010;138:1704-13
42. Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF.: A cohort study
of missed and new cancers after esophagogastroduodenoscopy. Am J
Gastroenterol 2010;105(6):1292-97.
43. Lee TH, Cho JY, Chang YW, Kim JO, Lee JS, Cho WY et al.: Appropriate
indications for endoscopic submucosal dissection of early gastric cancer according
to tumor size and histologic type. Gastrointest Endosc 2010;71(6):920-26.
44. Kang HY, Kim SG, Kim JS, Jung HC, Song IS.: Clinical outcomes of endoscopic
submucosal dissection for undifferentiated early gastric cancer. Surg Endosc
2010;24(3):509-16.
45. Lee CK, Chung IK, Lee SH, Kim SP, Lee SH, Lee TH et al.: Is endoscopic forceps
biopsy enough for a definitive diagnosis of gastric epithelial neoplasia? J
Gastroenterol Hepatol 2010;25(9):1507-13.
46. Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC et al.: Histologic diagnosis
based on forceps biopsy is not adequate for determining endoscopic treatment of
gastric adenomatous lesions. Endoscopy 2010;42(8):620-26.
47. Sumiyama K, Tajiri H, Gostout CJ, Kawamura M, Imazu H, Ohya TR et al.:
Chemically assisted submucosal injection facilitates endoscopic submucosal
dissection of gastric neoplasms. Endoscopy 2010;42(8):627-32.
48. Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH et al.: Covered versus
uncovered self-expandable metallic stents for palliation of malignant pyloric
obstruction in gastric cancer patients: a randomized, prospective study.
Gastrointest Endosc 2010;72(1):25-32.
49. Kato M, Nishida T, Tsutsui S, Komori M, Michida T, Yamamoto K et al.:
Endoscopic submucosal dissection as a treatment for gastric noninvasive
neoplasia: a multicenter study by Osaka University ESD Study Group. J
Gastroenterol 2010 Nov 25. [Epub ahead of print]
50. Fernández-Esparrach G, Sendino O, Solé M, Pellisé M, Colomo L, Pardo A et al.:
Endoscopic ultrasound-guided fine-needle aspiration and truecut biopsy in the
diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy
2010;42(4):292-99.
51. Enomoto S, Maekita T, Ohata H, Yanaoka K, Oka M, Ichinose M.: Novel risk
markers for gastric cancer screening: Present status and future prospects. World
Journal of Gastrointest Endosc 2010; 16; 2(12): 381-87.
52. Moschetta M, Stabile Ianora AA, Anglani A, Marzullo A, Scardapane A, Angelelli
G: Preoperative T staging of gastric carcinoma obtained by MDCT vessel probe
reconstructions and correlations with histological findings. Eur Radiol 2010;20:
138–145
53. Pan Z, Zhang H, Yan Ch, Du L, Ding B, Song Q, Ling H, Huang B, Chen K:
Determining gastric cancer resectability by dynamic MDCT. Eur Radiol 2010;20:
613-620
54. Lee IJ, Lee JM, Kim SH, Shin Ch, Lee JY, Kim SH, Han JK, Choi BI: Diagnostic
Performance of 64-Channel Multidetector CT in the Evaluation of Gastric Cancer:
Differentiation of Mucosal Cancer (T1a) from Submucosal Involvement (T1b and
T2). Radiology 2010;255:805-814.
55. Chen C-Y, Jaw T-S, Wu D-C, Kuo Y-T, Lee C-H, Huang W-T, Liu G-C: MDCT of
Giant Gastric Folds: Differential Diagnosis. AJR 2010; 195:1124-1130
56. Tan CH, Peungjesada S, Charnsangavej C, Bhosale P: Gastric Cancer: Patterns of
Disease Spread via the Perigastric Ligaments Shown by CT. AJR 2010; 195:398-
404
57. Johnson PT, Horton KM, Fishman EK: Hypervascular Gastric Masses: CT
Findings and Clinical Correlates. AJR 2010; 195:W415-W420
58. Biondi A, Persiani R, Cananzi F, Zoccali M et al.: R0 resection in the treatment of
gastric cancer: room for improvement. World J Gastroenterol. 2010;
21;16(27):3358-70.
59. Sharpe D, Williams RN, Ubhi SS, Sutton CD etal.: The „two-week wait” referral
pathway allows prompt treatment but does not improve outcome for patients with
oesophago-gastric cancer. Eur J Surg Oncol. 2010;36(10):977-81
60. Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK et al.: Enforcing
centralization for gastric cancer in Denmark. Eur J Surg Oncol. 2010;36 Suppl
1:S50-4.
61. Sierzega M, Kolodziejczyk P, Kulig J; Polish Gastric Cancer Study Group. Impact
of anastomotic leakage on long-term survival after total gastrectomy for carcinoma
of the stomach. Br J Surg. 2010;97(7):1035-42.
62. Yonemura Y, Endou Y, Sasaki T, Hirano M et al.: Surgical treatment for peritoneal
carcinomatosis from gastric cancer. Eur J Surg Oncol. 2010 ec;36(12):1131-8.
63. Glehen O, Gilly FN, Arvieux C, Cotte E et al.: Peritoneal carcinomatosis from
gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive
surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg
Oncol. 2010;17(9):2370-7.
64. La Torre M, Ferri M, Giovagnoli MR, Sforza N et al.: Peritoneal wash cytology in
gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J
Surg Oncol. 2010;36(10):982-6.
65. Roviello F, Pedrazzani C, Marrelli D, Di Leo A et al.: Super-extended (D3)
lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36(5):439-
46.
66. Sun Z, Xu Y, Li de M, Wang ZN et al.: Log odds of positive lymph nodes: a novel
prognostic indicator superior to the number-based and the ratio-based N category
for gastric cancer patients with R0 resection. Cancer. 2010; 1;116(11):2571-80.
67. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ.: Surgical
treatment of gastric cancer: 15-year follow-up results of the randomised
nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-49.
68. Zhang H, Liu C, Wu D, Meng Y. et al.: Does D3 surgery offer a better survival
outcome compared to D1 surgery for gastric cancer? A result based on a hospital
population of two decades as taking D2 surgery for reference. BMC Cancer
2010;20;10:308.
69. Saito H, Kuroda H, Matsunaga T, Fukuda K et al.: Prognostic indicators in nodenegative advanced gastric cancer patients. J Surg Oncol. 2010;1;101(7):622-5.
70. Schuhmacher C, Gretschel S, Lordick F, Reichardt P. et al.: Neoadjuvant
chemotherapy compared with surgery alone for locally advanced cancer of the
stomach and cardia: European Organisation for Research and Treatment of Cancer
randomized trial 40954. J Clin Oncol. 2010;10;28(35):5210-8.
71. Dikken JL, Jansen EP, Cats A, Bakker B. et al.: Impact of the extent of surgery
and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J
Clin Oncol. 2010;10;28(14):2430-6.
72. Kim HH, Hyung WJ, Cho GS, Kim MC. et al.: Morbidity and mortality of
laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim
report–a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann
Surg. 2010;251(3):417-20.
73. Kodera Y, Fujiwara M, Ohashi N, Nakayama G. et al.: Laparoscopic surgery for
gastric cancer: a collective review with meta-analysis of randomized trials. J Am
Coll Surg. 2010;211(5):677-86.
74. Yamamoto H, Kojima A, Miyasaka Y, Imamura M. et al.: Prognostic impact of
blood vessel invasion in gastrointestinal stromal tumor of the stomach. Hum
Pathol. 2010;41(10):1422-30.
75. Maor Y, Avidan B, Melzer E, Bar-Meir S.: Long-term clinical outcome of patients
with gastric gastrointestinal stromal tumors. Dig Dis Sci. 2010;55(10):2893-8.
76. Krejs GJ.: Gastric cancer: epidemiology and risk factors Dig Dis. 2010;28(4-
5):600-3. Epub 2010 Nov 18
77. Lázár DA.r, S. Tabán, I. Sporea et al.: Ki-67 expression in gastric cancer. Results
from a prospective study with long-term follow-up Romanian Journal of
Morphology and Embryology 2010;51(4):655–661
78. Okines A., M. Verheij, W. Allum et al.: Gastric cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up (On behalf of the ESMO
Guidelines Working Group) Annals of Oncology 2010;21 (Supplement 5):50–54:
79. Washington K.: 7th Edition of the AJCC Cancer Staging Manual: Stomach Ann
Surg Oncol 2010;17:3077-3079
80. Ma Y., Y- Xue ,Y. Li et al.: Subclassification of Stage IV Gastric Cancer (IVa, IVb,
and IVc) and Prognostic Significance of Substages J Gastrointest Surg
2010;14:484–492
81. The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International
Collaboration) Group Benefit of Adjuvant Chemotherapy for Resectable Gastric
Cancer A Meta-analysis JAMA. 2010;17:1729-1737
82. Kulig J. P. Kolodziejczyk M. Sierzega et al.( Polish Gastric Cancer Study
Group): Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin
Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III
Randomized, Multicenter, Clinical Trial Oncology; 2010;78:54–61
83. Bamias A., M. Karina, P. Papakostas et al.: A randomized phase III study of
adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in
patients with gastric cancer Cancer Chemother Pharmacol 2010;65:1009–1021
84. Kwon H-C., MC Kim, KH Kim et al.: Adjuvant chemoradiation versus
chemotherapy in completely resected advanced gastric cancer with D2 nodal
dissection Asia–Pacific Journal of Clinical Oncology 2010;6: 278–285
85. Mezhir JJ., LH Tang et al: Neoadjuvant Therapy of Locally Advanced Gastric
Cancer Journal of Surgical Oncology 2010;101:305–314
86. Ajani JA., W. Rodriguez, Gy. Bodoky, et al.: Multicenter Phase III Comparison of
Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or
Gastroesophageal Adenocarcinoma Study: The FLAGS Trial J Clin Oncol
2010;28:1547-1553
87. Kulka J., I Szirtes, AM Szász, P Kupcsulik, I Kenessey, G Lotz, J Tímár: A
gyomorrák kezelésének aktualitásai: A gyógyszeres kezelés patológiai alapjai és
háttere, minőségbiztosítás a patológiában Magyar Onkológia 2010;54:343–350
88. Bang YJ., E Van Cutsem A Feyereislova et al.: Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of HER2-positive
advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled trial The Lancet, 2010;28: 687 – 697
89. Tebbutt NC., MM Cummins et al.: Australasian Gastro-Intestinal Trials Group
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin
and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG
ATTAX trial British Journal of Cancer 2010;102, 475 – 481
90. Yun J., J-Lee,.Se Hoon Park, et al.: A randomised phase II study of combination
chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and
capecitabine (CX) in advanced gastric cancer European Journal of Cancer
2010;46;885-891
91. Kim JY., YR Do ,KU. Park et al: Multicenter phase II trial of S-1, paclitaxel and
cisplatin triplet combination chemotherapy in patients with advanced gastric
Cancer Cancer Chemother Pharmacol 2010; 67:527–532 (2011) online pub
92. Gubanski M., A Johnson, E Fernebro et al: Randomized phase II study of
sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in
patients with advanced gastric cancer: the GATAC trial Gastric Cancer 2010;13:
155–161
93. Wang DL., DY Gu, HY Huang et al.: Irinotecan-involved regimens for advanced
gastric cancer: A pooled-analysis of clinical trials World J Gastroenterol 2010;16
(46): 5889-5894
94. Rao S., N. Starling,D. Cunningham et al: Matuzumab plus epirubicin, cisplatin and
capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as
first-line treatment in patients with advanced oesophago-gastric cancer: a
randomised, multicentre open-label phase II study Annals of Oncology 2010;21:
2213–2219
95. Lordick F., B Lube, S Lorenzen et al.: Cetuximab plus oxaliplatin/leucovorin/5-
fluorouracil in first-line metastatic gastric cancer: a phase II study of the
Arbeitsgemeinschaft Internistische Onkologie (AIO) British Journal of Cancer
2010;102: 500-505
96. Sun W., M. Powell, J. O’Dwyer, P Catalano, R H. Ansari, Al B. Benson: III Phase
II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the
Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction
Adenocarcinoma: ECOG 5203 J Clin Oncol 2010;28:2947-2951
97. Bang YJ. ,YK Kang,WK. Kang et al.: Phase II study of sunitinib as second-line
treatment for advanced gastric cancer Invest New Drugs 2010 May 12.
98. Doi T., K. Muro, N. Boku, et al.: Multicenter Phase II Study of Everolimus in
Patients With Previously Treated Metastatic Gastric Cancer J Clin Oncol
2010;28:1904-1910
99. Reddymasu SC., Sarosiek I., McCallum W.: Severe gastroparesis: medical therapy
of gastric electrical stimulation Clin Gastroenterol Hepatol 2010;8:117-24
100. McCallum RW., Snape W., Brody F.: Gastric electrical stimulation with
Enterra therapy improves symptoms from diabetic gastroparesis in prospective
study Clin. Gastroenterol Hepatol 2010;8:947-54
101. Tavakkoli A., Talley N., Baldwin D. et al.: Gastroparesis is not associated
with acid or nonacid reflux Am J Gastroenterol 2010;105(Suppl 1):S32
102. Roberts-Thomson IC, Singh R, Edward T, Nguyen NQ, Lidums I.: The
future of endoscopy. J of Gastroenterol and Hepatol 2010;25:1051–57.
103. Bnerjee S, Jay P.: Embracing New Technology in the Gastroenterology
Practice. Clin Gastroenterol Hepatol 2010;8:848–50.
104. Curvers WL, Herrero LA, Wallace MB, Wong Kee Song LM, Ragunath K,
Wolfsen HC et al.: Endoscopic Tri-Modal Imaging Is More Effective Than
Standard Endoscopy in Identifying Early-Stage Neoplasia in Barrett’s Esophagus.
Gastroenterology 2010;139:1106–14.
105. Kochhar R, Kochhar S.: Endoscopic balloon dilation for benign gastric
outletobstruction in adults. World J Gastrointest Endosc 2010;16; 2(1): 29-35.
106. Hijikata Y, Ogasawara N, Sasaki M, Mizuno M, Masui R, Tokudome K et
al.: Endoscopic submucosal dissection with sheath-assisted counter traction for
early gastric cancers. Dig Endosc 2010;22(2):124-28.
107. Parra-Blanco A, Arnau MR, Nicolás-Pérez D, Gimeno-García AZ,
González N, Díaz-Acosta et al.: Endoscopic submucosal dissection training with
pig models in a Western country. World J Gastroenterol. 2010;21;16(23):2895-
900.
108. Hu CT.: Gauze pledgetting versus endoscopic-guided aerosolized spray for
nasal anesthesia before transnasal EGD: a prospective, randomized study.
Gastrointest Endosc 2010;71(1):11-20.
109. Ibrahim M, Blero D, Deviere J.: Endoscopic options for the treatment of
obesity. Gastroenterology 2010;138:2228-32.
110. De Jong K, Mathus–Vliegen EMH, Weldhuyzen EAML, et al.: Shortterm
safety and efficacy of the transoral endoscopic restrictive implant system for the
treatment of obesity. Gastrointest Endosc [in press].
111. Schigt A, Scholten P, van Wagensveld BA.: Is There a Place for
Preoperative Gastroscopy in Morbidly Obese Patients Undergoing Gastric Bypass
Surgery? Gastroenterology 2010;138 (S1): 389.
112. Fernandez-Esparrach G, Lautz DB, Thompson CC.: Endoscopic repair of
gastrogastric fistula after Roux-en-Y gastric bypass: a less-invasive approach. Surg
Obes Relat Dis 2010;6(3):282-88.
113. Bhardwaj A, Cooney RN, Wehrman A, Rogers AM, Mathew A.: Endoscopic
repair of small symptomatic gastrogastric fistulas after gastric bypass surgery: a
single center experience. Obes Surg 2010;20(8):1090-95.
114. Campos JM, Evangelista LF, Galvão Neto MP, Ramos AC, Martins JP, dos
Santos MA Jr. et al.: Small erosion of adjustable gastric band: endoscopic removal
through incision in gastric wall. Surg Laparosc Endosc Percutan Tech
2010;20(6):e215-17.
115. Campillo-Soto A, Torralba-Martínez JA, Martín-Lorenzo JG, Lirón-Ruiz R,
Bento-Gerard M, Pérez-Cuadrado E et al.: Gastrojejunal anastomosis stricture
after laparoscopic gastric bypass. Our experience with 62 patients. Rev Esp
Enferm Dig 2010;102(3):187-92
116. Himpens J, Dobbeleir J, Peeters G.: Long-term results of laparoscopic
sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319-24
117. Xiao C., Ogle SA., Schumacher MA. et al.: Loss of parietal cell expression of
Sonic Hedghog induces hypergastrinaemia and hyperproliferation of surface mocous
cells Gastroenterology 2010;138:550-561
118. Waghray M., Zavros Y., Saqui-Salces M. et al.: Interleukin-1β promotes gastric
atrophy through suppression of Sonic Hedgehog Gastroenterology 2010;138:562-72
119. Van Dop WA., Van den Brink GR.: Sonic Hedgehog: A link between
inflammation, gastric atrophy, and acid suppression? Gastroenterology 2010;138:426-
9
120. Merriman NA, Putt ME., Yang Y-X.: Hip fracture risk in patients with a
diagnosis of pernicious anaemia Gastroenterology 2010;138:1330-7
121. Adachi S., Takiguchi S., Okada K. et al.: Effects of ghrelin administration
after total gastrectomy: A prospective, randomized, placebo-controlled phase II.
study Gastroenterology 2010;138:1312-20
122. Curcic J, Fox M, Kaufman E, Forras-Kaufman ZS, Hebbard GS, Roy S, Pal
A, Schwizer W, Fried M, Treier R, Boesiger P: Gastroesophageal Junction:
Structure and Function as Assessed by Using MR Imaging. Radiology
2010;257:115-124
123. de Zwart IM, de Roos A: MRI for the evaluation of gastric physiology. Eur
Radiol (2010) 20: 2609-2616
124. Mine S, Sano T, Tsutsumi K, Murakami Y et al.: Large-scale investigation
into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg.
2010;211(5):628-36
125. Nau P, Ellison EC, Muscarella P Jr, Mikami D et al.: A review of 130
humans enrolled in transgastric NOTES protocols at a single institution. Surg
Endosc. 2010 Oct 26. [Epub ahead of print]
